Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Net Margin (2020 - 2022)

Immuneering (IMRX) has 3 years of Net Margin data on record, last reported at 2960184.62% in Q4 2022.

  • For Q4 2022, Net Margin fell 295439696.0% year-over-year to 2960184.62%; the TTM value through Sep 2023 reached 11588326.81%, down 1157879597.0%, while the annual FY2022 figure was 15937.29%, 1432497.0% down from the prior year.
  • Net Margin reached 2960184.62% in Q4 2022 per IMRX's latest filing, down from 33781.05% in the prior quarter.
  • Across five years, Net Margin topped out at 644.49% in Q3 2020 and bottomed at 2960184.62% in Q4 2022.
  • Average Net Margin over 3 years is 335928.49%, with a median of 5787.65% recorded in 2021.
  • Peak YoY movement for Net Margin: tumbled -112391bps in 2021, then crashed -295439696bps in 2022.
  • A 3-year view of Net Margin shows it stood at 644.49% in 2020, then tumbled by -798bps to 5787.65% in 2021, then tumbled by -51047bps to 2960184.62% in 2022.
  • Per Business Quant database, its latest 3 readings for Net Margin were 2960184.62% in Q4 2022, 33781.05% in Q3 2022, and 12183.19% in Q2 2022.